Enjoy complimentary customisation on priority with our Enterprise License!
The bromhidrosis disease treatment market size is forecast to increase by USD 277 million, at a CAGR of 7.08% between 2023 and 2028. Market growth hinges on several key factors. Firstly, there is a rising number of patients affected by diabetes and kidney diseases, driving demand for healthcare products and services tailored to managing these conditions effectively. Secondly, increased government awareness programs about these diseases contribute to early detection and treatment, further boosting market growth. Thirdly, improved healthcare affordability in the US allows more individuals to access essential medical treatments and services, expanding the customer base for pharmaceuticals and medical devices. These factors collectively create a conducive environment for growth in the healthcare sector, fostering innovation, investment, and market expansion to meet the evolving needs of patients and healthcare providers alike.
For More Highlights About this Report, Request Free Sample
Bromhidrosis, also known as body odor, is a common condition caused by the overgrowth of bacteria in the sweat glands. The disease affects millions of people worldwide, leading to social embarrassment and discomfort. The treatment market for bromhidrosis is diverse, ranging from home remedies to medical interventions. Home remedies include the use of unsaturated fatty acids, such as tea tree oil and apple cider vinegar, to maintain hygiene and kill bacteria. Topical antiseptics like Clindamycin and Erythromycin are commonly prescribed medications for mild cases. For severe cases, medical interventions such as surgery, Botox injections, and liposuction are used. Botulinum Toxin, a type of Botox, is injected into the sweat glands to temporarily stop the production of sweat. Dermatology practices emphasize sanitary practices, such as regular bathing and wearing breathable clothing, to manage the condition. Laser interference is another treatment option that uses laser technology to destroy the sweat glands. Chronic skin diseases like Trichomycosis Axillaris, Erythrasis, Intertrigo Skin Rash, Osmidrosis, and Type 2 Diabetes can also cause bromhidrosis, requiring specific medications and treatments. The market for bromhidrosis treatments is driven by factors such as beauty consciousness, anti-aging treatments, and the increasing prevalence of chronic skin diseases and diabetes. The market is expected to grow significantly in the coming years due to the increasing awareness and availability of effective treatments. Hospitals and drug stores are the major distribution channels for these treatments.
Rise in the number of patients affected by diabetes and kidney diseases is notably driving market growth. The global market for bromhidrosis disease treatment is experiencing significant growth due to the increasing number of patients suffering from kidney diseases, a major cause of abnormal body odors. According to recent statistics, approximately 8.5%-9.5% of the adult population worldwide is affected by chronic kidney disease (CKD). Diabetes, hypertension, vascular disease, and glomerulonephritis are among the leading causes of CKD. In developing countries, infections such as glomerulonephritis and interstitial nephritis are the primary contributors to CKD.
Although CKD can affect people of all ages, it is more prevalent among the elderly, with a higher incidence in those aged 65 years and above. Treatment options for bromhidrosis caused by kidney diseases include antibiotics such as Clindamycin and Erythromycin, which help reduce bacterial count. Topical antiseptics are also used to prevent infection and maintain hygiene. While hospital treatment can be effective, it is often expensive. Therefore, drug stores and pharmacies offer more affordable alternatives for patients. Thus, such factors are driving the growth of the market during the forecast period.
Increasing number of M&A by companies is the key trend in the market. The global bromhidrosis disease treatment market is witnessing significant developments due to several strategic mergers and acquisitions (M&A) among key players. For instance, in May 2022, Pfizer Inc. announced its acquisition of Biohaven Pharmaceutical Holding Company Ltd. to commercialize CGRP receptor antagonists outside the US. Similarly, in February 2022, Ipsen Pharma entered into exclusive negotiations with Mayoly Spindler for the sale of its global consumer healthcare business. These strategic moves aim to expand the product portfolio and gain access to new technologies at a reasonable cost.
Moreover, the aging population and the increasing prevalence of kidney diseases are major factors fueling the demand for effective bromhidrosis disease treatments. Topical antiseptics such as Clindamycin and Erythromycin are commonly used for treating bromhidrosis. However, the high cost of hospital treatments and expensive drugs make it challenging for patients to afford these treatments. Therefore, there is a growing trend towards the use of over-the-counter topical antiseptics available at drug stores. Thus, such trends will shape the growth of the market during the forecast period.
High cost of treatment is the major challenge that affects the growth of the market. Bromhidrosis, a condition characterized by excessive body odor caused by bacterial growth in sweat, can be treated through various non-surgical and surgical methods. Preventative measures, such as topical antiseptics like Clindamycin and Erythromycin, are effective for mild cases. However, for severe bromhidrosis, surgical intervention may be necessary. This includes removing the affected sweat glands or utilizing injectables that inhibit nerve signals to the sweat glands, reducing sweating.
Although effective, these treatments can be expensive, with costs ranging from USD 600 to USD 1,500. The aging population's increasing prevalence of kidney diseases and related complications, including bromhidrosis, is driving the demand for effective treatment options. Despite the high cost, these treatments remain a crucial solution for those suffering from debilitating body odor. Hence, the above factors will impede the growth of the market during the forecast period
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
AbbVie Inc. - The company offers bromhidrosis disease treatment namely Botox.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The apocrine body odor segment is estimated to witness significant growth during the forecast period. Apocrine bromhidrosis, a type of bromhidrosis, is the most prevalent form of body odor in adults, primarily affecting the armpits and anogenital region. Apocrine glands, situated in the underarm, groin, and breast areas, produce thicker sweat than eccrine glands. This sweat, initially odorless and colorless, becomes malodorous when bacteria metabolize dried perspiration. Activation of apocrine sweatglands occurs during puberty, resulting in body odor becoming a concern. The sympathetic nervous system regulates apocrine sweat production. Various treatment modalities are available for bromhidrosis, including home remedies, medications, surgeries, and medical devices.
Get a glance at the market share of various regions Download the PDF Sample
The apocrine body odor was the largest and was valued at USD 370.80 million in 2018. Awareness campaigns and addressing the stigma associated with body odor are essential. Chronic skin diseases like Trichomycosis Axillaris, Erythrasma, Intertrigo Skin Rash, and Osmidrosis can co-occur with bromhidrosis. Diabetes, Type 2, can also contribute to increased sweating and body odor. Medical devices like laser sweat ablation and laser interference can be effective in managing excessive sweating. Dermatology practices and healthcare insurance coverage can impact the affordability and accessibility of these treatments. Quality of life is significantly affected by bromhidrosis, and addressing it is crucial. Unsaturated fatty acids can help reduce bacterial growth and improve body odor. Maintaining good sanitary practices is essential in preventing and managing bromhidrosis. Beauty consciousness and anti-aging treatments are also driving the demand for effective bromhidrosis treatments.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Bromhidrosis, also known as excessive body odor, can be caused by various factors including Trichomycosis Axillaris, Erythrasma, Intertrigo Skin Rash, and Type 2 Diabetes. Treatment modalities include both medical and home remedies. Botox injections and surgery, such as liposuction, are invasive options used to address severe cases. Botulinum toxin injections, which inhibit nerve signals to the sweat glands, are effective for hyperhidrosis in the armpits and feet. Medications like antiperspirants containing aluminum salts, topical antibiotics, oral medications, and anticholinergics are commonly prescribed. Home remedies include the use of tea tree oil, apple cider vinegar, and baking soda. Awareness campaigns are essential to reduce the stigma associated with bromhidrosis.
Further, medical devices like laser sweat ablation and laser interference can also be effective. Healthcare professionals recommend good sanitary practices, dermatology practices, and anti-aging treatments to maintain skin health. Chronic skin diseases, diabetes, and beauty consciousness are significant factors driving the demand for bromhidrosis disease treatment. Healthcare expenditure and insurance coverage vary, making affordability a concern for many. Osmidrosis, caused by bacteria, can worsen bromhidrosis, emphasizing the importance of proper hygiene and unsaturated fatty acids in the diet.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD million" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.
You may also interested in below market reports:
Bromhidrosis, also known as body odor, is a common condition that affects millions of people worldwide. The disease is caused by excessive sweat production and bacterial growth in the armpits or feet. Treatment options for bromhidrosis include various modalities, from home remedies to surgical interventions. Botox injections and liposuction are surgical treatments for severe cases of underarm bromhidrosis. Home remedies, such as using antiperspirants with aluminum salts, topical antibiotics, and oral medications, are effective for mild to moderate cases. Anticholinergics and botulinum toxin injections are also used to block nerve signals that stimulate sweat glands. Trichomycosis axillaris, erythrasma, and intertrigo skin rash are conditions that can cause bromhidrosis and require medical attention. Type 2 diabetes and chronic skin diseases can also contribute to the disease. Healthcare professionals are emphasizing the importance of good hygiene practices, such as regular bathing and using antiperspirants, to prevent bromhidrosis. Awareness campaigns and stigma reduction efforts are also essential to encourage people to seek treatment.
Medical devices, such as laser sweat ablation, are becoming increasingly popular for treating bromhidrosis. Healthcare expenditure and insurance coverage for these treatments are important considerations for individuals seeking relief from the condition. Bacteria, unsaturated fatty acids, and laser interference are some of the factors that influence the development and treatment of bromhidrosis. Dermatology practices and sanitary practices also play a crucial role in managing the disease. In summary, bromhidrosis treatment market includes various modalities, from home remedies to surgical interventions, and medical devices. Factors such as healthcare expenditure, Health insurance coverage, and awareness campaigns influence the market. Botox, liposuction, antiperspirants, topical antibiotics, oral medications, anticholinergics, and botulinum toxin injections are some of the key treatments for bromhidrosis. Other conditions, such as diabetes, can contribute to the disease, making it essential to address the root cause for effective treatment.
Market Scope |
|
Report Coverage |
Details |
Page number |
131 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.08% |
Market growth 2024-2028 |
USD 277 million |
Market structure |
Concentrated |
YoY growth 2023-2024(%) |
6.48 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 40% |
Key countries |
US, Canada, Germany, China, and UK |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
AbbVie Inc., Biovencer Healthcare Pvt. Ltd., Boehringer Ingelheim International GmbH, Galderma SA, Hikma Pharmaceuticals Plc, Ipsen Pharma, Johnson and Johnson Services Inc., JOURNEY MEDICAL CORP., Medytox, Merz Pharma GmbH and Co KGaA, Novartis AG, and Pfizer Inc. |
Market dynamics |
Parent market growth analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for market forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.